In vitro cytotoxicity of Selol-loaded magnetic nanocapsules against neoplastic cell lines under AC magnetic field activation

Journal of Applied Physics

Volumn 111, Issue 7, 2012, Pages

  Falqueiro, A M ^a   Siqueira Moura, M P ^a   Jardim, D R ^a   Primo, F L ^a   Morais, P C ^b   Mosiniewicz Szablewska, E ^c   Suchocki, P ^d,e   Tedesco, A C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c INSTITUTE OF PHYSICS   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3-(4 ,5-DIMETHYLTHIAZOL-2-YL)-2 ,5-DIPHENYL TETRAZOLIUM BROMIDE; AC MAGNETIC FIELDS; ANTI-TUMORAL ACTIVITY; APPLIED FIELD; CANCER CELLS; CARCINOMA CELLS; CELL LINES; CELL VIABILITY; CYTOTOXIC EFFECTS; DRUG RESISTANCE; IN-VITRO; MAGHEMITES; MAGNETIC NANOCAPSULES; MAGNETIC NANOMATERIALS; MELANOMA CELLS; NANOPRECIPITATION METHOD; NEOPLASTIC CELLS; SQUAMOUS CELL CARCINOMA; THERAPEUTIC POTENTIALS; TOXIC EFFECT;

BROMINE COMPOUNDS; CELL CULTURE; CELLS; CYTOTOXICITY; DERMATOLOGY; IRON ORES; MAGNETIC FIELDS; MAGNETIC FLUIDS; ONCOLOGY;

NANOCAPSULES;

EID: 84861722131     PISSN: 00218979     EISSN: None     Source Type: Journal    
DOI: 10.1063/1.3680541     Document Type: Conference Paper

References (17)

1. Q. A. Punkhurst, J. Connolly, S. K. Jones, and J. Dobson, J. Phys. D: Appl. Phys. 36, R167 (2003). 10.1088/0022-3727/36/13/201
2. R. Hergt, W. Andra, C. G. D'ambly, I. Hilger, W. A. Kaiser, U. Richter, and H. Schmidt, IEEE Trans. Magn. 34, 3745 (1998). 10.1109/20.718537
3. R. E. Rosensweig, J. Magn. Magn. Mater. 252, 370 (2002). 10.1016/S0304-8853(02)00706-0
4. Y. Lv, Z. Deng, and J. Liu, IEEE Trans. Nanobiosci. 4, 284 (2005). 10.1109/TNB.2005.859549
5. P. Tartaj, M. del Puerto Morales, S. Veintemillas-Verdaguer, T. Gonzlez-Carreo, and C. J. Serna, J. Phys. D: Appl. Phys. 36, 182 (2003). 10.1088/0022-3727/36/13/202
6. P. Suchocki, I. Misiewicz, K. Skupiska, K. Wacawek, Z. Fijaek, and T. Kasprzycka-Guttman, Oncol. Rep. 18, 893 (2007).
7. B. Fitak, M. Grabowski, and P. Suchocki, Patent (Pol. Pl 176530 (Cl. A61K31/095), Warsaw, Poland, 30 Jun 1999.
8. P. Suchocki, I. Misiewicz-Krzemiska, K. Skupiska, K. Niedwiedzka, K. Lubelska, Z. Fijaek, and T. Kasprzycka-Guttman, Pharmacological Rep. 62, 352 (2010). 10.1016/j.phrs.2010.05.006
9. Y. Matsumura and H. Maeda, Cancer Res. 46, 6387 (1986).
10. C. E. Mora-Huertas, H. Fessi, and A. Elaissari, Int. J. Pharm. 385, 113 (2010). 10.1016/j.ijpharm.2009.10.018
11. A. R. Simioni, F. L. Primo, M. M. A. Rodrigues, Z. G. M. Lacava, P. C. Morais, and A. C. Tedesco, IEEE Trans. Magn. 43, 2459 (2007). 10.1109/TMAG.2007.894126
12. A. M. Falqueiro, F. L. Primo, P. C. Morais, E. Mosiniewicz-Szablewska, P. Suchocki, and A. C. Tedesco, J. Appl. Phys. 109, 07B306ZZ (2011). 10.1063/1.3556950
13. T. Mosmann, J. Immunol. Methods 65, 55 (1983). 10.1016/0022-1759(83) 90303-4
14. S. I. Parka, Y. H. Hwangb, J. H. Limb, J. H. Kimc, H. I. Yunb, and C.O. Kim, J. Magn. Magn. Mater. 304, E403 (2006). 10.1016/j.jmmm.2006.01.204
15. J. Dobson, Drug. Dev. Res. 67, 55 (2006). 10.1002/ddr.v67:1
16. R. Hergt, S. Dutz, R. Muller, and M. Zeisberger, J. Phys.: Condens. Matter 18, S2919 (2006). 10.1088/0953-8984/18/38/S26
17. I. Ankareddi and C. S. Brazel, Int. J. Pharm. 336, 241 (2006). 10.1016/j.ijpharm.2006.11.065